BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32451988)

  • 1. Prognostic Role of Krüppel-Like Factors 5, 9, and 11 in Endometrial Endometrioid Cancer.
    Viola L; Londero AP; Bertozzi S; Orsaria M; Marzinotto S; Antoniazzi F; Renda V; Cinel J; Fruscalzo A; Lellé RJ; Mariuzzi L
    Pathol Oncol Res; 2020 Oct; 26(4):2265-2272. PubMed ID: 32451988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of progesterone and estrogen receptors expression in tissue microarray method in prognosis of patients with endometrioid endometrial cancer].
    Gottwald L; Kubiak R; Pasz-Walczak G; Sek P; Piekarski J; Szwalski J; Spych M; Chałubińska-Fendler J; Suzin J; Tyliński W; Jeziorski A
    Ginekol Pol; 2013 Feb; 84(2):95-101. PubMed ID: 23668054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of Ki-67 antigen expression in tissue microarray method in prediction prognosis of patients with endometrioid endometrial cancer].
    Gottwald L; Kubiak R; Sek P; Piekarski J; Szwalski J; Pasz-Walczak G; Spych M; Suzin J; Tylińskis W; Jeziorski A
    Ginekol Pol; 2013 Jun; 84(6):444-9. PubMed ID: 24032262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
    Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
    Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin, sonic hedgehog, krüppel-like factors, and p53 pathway in serous ovarian cancer: an immunohistochemical study.
    Londero AP; Orsaria M; Viola L; Marzinotto S; Bertozzi S; Galvano E; Andreetta C; Mariuzzi L
    Hum Pathol; 2022 Sep; 127():92-101. PubMed ID: 35777700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of ARID1A Expression as a Favorable Prognostic Factor in Early-Stage Grade 3 Endometrioid Endometrial Carcinoma Patients.
    Kato MK; Yoshida H; Tanase Y; Uno M; Ishikawa M; Kato T
    Pathol Oncol Res; 2021; 27():598550. PubMed ID: 34257552
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
    Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleaved caspase-3 expression is a potential prognostic factor for endometrial cancer with positive peritoneal cytology.
    Ogane N; Yasuda M; Kato H; Kato T; Yano M; Kameda Y; Kamoshida S
    Cytopathology; 2018 Jun; 29(3):254-261. PubMed ID: 29626374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L1 Cell Adhesion Molecule (L1CAM) expression in endometrioid endometrial carcinomas: A possible pre-operative surrogate of lymph vascular space invasion.
    de Freitas D; Aguiar FN; Anton C; Bacchi CE; Carvalho JP; Carvalho FM
    PLoS One; 2018; 13(12):e0209294. PubMed ID: 30557309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma.
    Steinbakk A; Malpica A; Slewa A; Skaland I; Gudlaugsson E; Janssen EA; Løvslett K; Fiane B; Kruse AJ; Feng W; Yinhua Y; Baak JP
    Mod Pathol; 2011 Sep; 24(9):1262-71. PubMed ID: 21552210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
    Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
    Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
    Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
    Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes.
    Bogani G; Tibiletti MG; Ricci MT; Carnevali I; Liberale V; Paolini B; Milione M; Vitellaro M; Murgia F; Chiappa V; Ditto A; Ghezzi F; Raspagliesi F
    Int J Gynecol Cancer; 2020 Jan; 30(1):56-61. PubMed ID: 31780564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
    Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
    Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
    Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
    Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of Twist1 and MMP-2 in endometrial endometrioid adenocarcinoma].
    Wang XJ; Chen XH
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):588-91. PubMed ID: 23158991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?
    Koyuncuoglu M; Okyay E; Saatli B; Olgan S; Akin M; Saygili U
    Gynecol Oncol; 2012 Apr; 125(1):208-13. PubMed ID: 22198340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
    Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
    Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.